About Orthobiologics
Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Orthobiologic products are obtained from naturally occurring materials. These products help treat people with long-term disabling musculoskeletal disorders and injuries. Innovations in orthobiologics led to the development of bone grafts and tissue regeneration products that accelerate the bone healing process, reducing hospital visits, and stays.
Technavios analysts forecast the global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global orthobiologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:
Stem cells
Bone morphogenetic proteins
Synthetic bone grafts
Viscosupplements
Demineralized bone matrix
Allografts
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavios report, Global Orthobiologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
DePuy Synthes
Medtronic
Sanofi
Stryker
Zimmer Biomet
Other prominent vendors
Alphatec Spine
AlloSource
AMEDICA
Anika Therapeutics
Arthrex
Baxter
BBS-Bioactive Bone Substitutes
Berkeley Advanced Biomaterial
Biomimetic Therapeutics
Bioventus
Bone Therapeutics
Ceramisys
Geistlich Bio-Oss
Graftys
Integra Life Sciences
ISTO Technologies
Keramat
K2M
NovaBone
Orthogem
Orthofix International
OsteoMed
RTI Surgical
Sigma Graft
Smith & Nephew
Straumann
Wright Medical
Xtant Medical
Market driver
Rise in strategic partnerships for marketing
For a full, detailed list, view our report
Market challenge
High cost of spine fusion surgery
For a full, detailed list, view our report
Market trend
Funds to enhance orthobiologics
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Funding for orthobiologics development
Orthobiologic products under clinical trial
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by product
Global orthobiologics market by stem cells
Global orthobiologics market by bone morphogenetic proteins
Global orthobiologics market by synthetic bone grafts
Global orthobiologics market by viscosupplements
Global orthobiologics market by demineralized bone matrix
Global orthobiologics market by allografts
PART 08: Market segmentation by procedure
Spinal fusion surgery
Orthopedic trauma and reconstruction surgery
PART 09: Geographical segmentation
Orthobiologics market in Americas
Orthobiologics market in EMEA
Orthobiologics market in APAC
PART 10: Market drivers
Popularity of spinal fusion surgeries
Rise in strategic
PARTnerships for marketing
Prevalence of arthritis
PART 11: Impact of drivers
PART 12: Market challenges
High cost of spinal fusion surgery
Product side effects and FDA scrutiny
Poor performance of bone graft substitute
PART 13: Impact of drivers and challenges
PART 14: Market trends
Funds to enhance orthobiologics
Product development in collaboration with research institutes
Increase in M&A
PART 15: Vendor landscape
Competitive scenario
Market share analysis
DePuy Synthes
Medtronic
Sanofi
Stryker
Zimmer Biomet
Other prominent vendors
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings 7
Exhibit 02: Funding for orthobiologics development
Exhibit 03: Global orthobiologics market segmentation by product and procedure
Exhibit 04: Global orthobiologics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global orthobiologics market by product 2015
Exhibit 07: Global orthobiologics market by stem cells 2015-2020 ($ millions)
Exhibit 08: Global orthobiologics market by bone morphogenetic proteins 2015-2020 ($ millions)
Exhibit 09: Global orthobiologics market by synthetic bone grafts 2015-2020 ($ millions)
Exhibit 10: Global orthobiologics market by viscosupplements 2015-2020 ($ billions)
Exhibit 11: Global orthobiologics market by demineralized bone matrix 2015-2020 ($ millions)
Exhibit 12: Global orthobiologics market by allografts 2015-2020 ($ millions)
Exhibit 13: Global orthobiologics market by procedure 2015
Exhibit 14: Global orthobiologics market by geography 2015
Exhibit 15: Orthobiologics market in Americas 2015-2020 ($ billions)
Exhibit 16: Orthobiologics market in EMEA 2015-2020 ($ billions)
Exhibit 17: Orthobiologics market in APAC 2015-2020 ($ millions)
Exhibit 18: Global orthobiologics market by geography 2015-2020
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Ranking of vendors 2015
Exhibit 22: Competitive scenario of vendors 2015
Exhibit 23: Comparative analysis of vendors and their orthobiologic products
Exhibit 24: Collaboration between vendors and universities or organizations
Exhibit 25: DePuy Synthes: Key takeaways
Exhibit 26: DePuy Synthes: Business segmentation
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Medtronic: Business segmentation by revenue 2015
Exhibit 29: Sanofi: Key takeaways
Exhibit 30: Sanofi: Product revenue 2014
Exhibit 31: Sanofi: Product revenue comparison 2013 and 2014 ($ millions)
Exhibit 32: Stryker: Key takeaways
Exhibit 33: Stryker: Business segmentation by revenue 2014
Exhibit 34: Stryker: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Stryker: Geographical segmentation by revenue 2014
Exhibit 36: Zimmer Biomet: Key takeaways
Exhibit 37: Zimmer Biomet: Business segmentation by revenue 2014
Exhibit 38: Zimmer Biomet: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Zimmer Biomet: Geographical segmentation by revenue 2014
